Do you want a flight stick to enhance your Microsoft Flight Simulator 2024 experience on PS5? One of the downsides to picking the game on Sony’s console right now as opposed to PC or even Xbox is that ...

Microsoft Flight Simulator 2024 is out now on the PS5 and it’s excellent, but it’s bound to get even better when it adds optional PSVR2 support next year. Those of you who own the headset will know ...

The best simulation games give us - regular people - the chance to do things we wouldn't usually get the chance to do. Sometimes, these are extraordinary, highly specialized activities, and sometimes ...

For all the would-be pilots out there and all those "Top Gun" fans, the Flightdeck Flight Simulation Center is for you. Here, you can pretend you're taking off, dogfighting, and completing ...

No matter if you wish to take to the skies on a leisurely ride across the Atlantic Ocean or gun down enemy combatants in action-packed dogfights, there are plenty of vastly different games where you ...

Learn how to master the DJI Fly App with this step‑by‑step DJI Fly App tutorial, covering essential DJI app settings and powerful drone flight tools for safer, pro‑level flights. Pixabay, Powie The ...

Build an empire, pilot a jumbo jet, or try your hand at industrial power-washing with these engrossing sim and sandbox games. In 2014, I began my career at PCMag as a freelancer. That blossomed into a ...

Investing.com - JPMorgan initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a $43.00 price target, citing the potential of its telitacicept drug. The target ...

There's a vast world of PC games that let you tackle the mundane in creative and surprisingly enjoyable ways. Build a PC, run a pizza shop, or become a bee with these strange and wondrous titles. In ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...

Investing.com - JPMorgan has initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a price target of $43.00, highlighting the potential of the company’s telitacicept ...

This week-long intensive immersion course provides participants with theory and hands-on training with leading-edge simulation skills. Exploring state-of-the-art computerized manikins (Human Patient ...